Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes

Journal of Substance Abuse Treatment

Volumn 32, Issue 4, 2007, Pages 423-429

  Heinzerling, Keith G ^a,b   Kral, Alex H ^c,d   Flynn, Neil M ^e   Anderson, Rachel L ^e   Scott, Andrea ^c,d   Gilbert, Mary L ^f   Asch, Steven M ^b,f   Bluthenthal, Ricky N ^f,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f RAND CORPORATION   (United States)

^g CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; HIV testing; Injection drug use; Syringe exchange programs

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DIRECTORY; FEMALE; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERVIEW; LEGAL ASPECT; MALE; PRIORITY JOURNAL; SOCIAL WORK; SYRINGE; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; DIAGNOSTIC SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34247519084     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.11.002     Document Type: Article

References (23)

1. Bluthenthal R.N., Kral A.H., Gee L., Erringer E.A., and Edlin B.R. The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS 14 (2000) 605-611
2. Bluthenthal R.N., Malik M.R., Grau L.E., Singer M., Marshall P., and Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 99 (2004) 1136-1146
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR. Recommendations and Reports 47 (1998) 1-39
4. Centers for Disease Control and Prevention. National hepatitis C prevention strategy: A comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences (2001), Center for Disease Control and Prevention, Atlanta, GA
5. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR. Recommendations and Reports 50 (2001) 1-57
6. Centers for Disease Control and Prevention. Update: Syringe exchange programs-United States, 2002. MMWR. Morbidity and Mortality Weekly Report 54 (2005) 673-676
7. Des Jarlais D.C., Fisher D.G., Newman J.C., Trubatch B.N., Yancovitz M., Paone D., et al. Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs. on-site vaccination at a syringe exchange program. American Journal of Public Health 91 (2001) 1791-1792
8. Downing M., Riess T.H., Vernon K., Mulia N., Hollinquest M., McKnight C., et al. What's community got to do with it? Implementation models of syringe exchange programs. AIDS Education and Prevention 17 (2005) 68-78
9. Friedman S.R., Lieb S., Tempalski B., Cooper H., Keem M., Friedman R., et al. HIV among injection drug users in large US metropolitan areas, 1998. Journal of Urban Health 82 (2005) 434-445
10. Gibson D.R., Flynn N.M., and Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15 (2001) 1329-1341
11. Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., and Alexander E.R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 19 (2000) 247-252
12. Hagan H., Thiede H., and Des Jarlais D.C. Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion. Epidemiology 15 (2004) 543-549
13. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases 186 (2002) 1558-1564
14. Heinzerling K.G., Kral A.H., Flynn N.M., Anderson R.L., Scott A., Gilbert M.L., et al. Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence 81 (2006) 167-178
15. Miller C.L., Johnston C., Spittal P.M., Li K., Laliberte N., Montaner J.S., et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36 (2002) 737-742
16. Miller C.L., Wood E., Spittal P.M., Li K., Frankish J.C., Braitstein P., et al. The future face of coinfection: Prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. Journal of Acquired Immune Deficiency Syndromes 36 (2004) 743-749
17. Murrill C.S., Weeks H., Castrucci B.C., Weinstock H.S., Bell B.P., Spruill C., et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. American Journal of Public Health 92 (2002) 385-387
18. Perlman D.C., Perkins M.P., Solomon N., Kochems L., Des Jarlais D.C., and Paone D. Tuberculosis screening at a syringe exchange program. American Journal of Public Health 87 (1997) 862-863
19. Spielberg F., Branson B.M., Goldbaum G.M., Lockhart D., Kurth A., Celum C.L., et al. Overcoming barriers to HIV testing: Preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. Journal of Acquired Immune Deficiency Syndromes 32 (2003) 318-327
20. Spielberg F., Branson B.M., Goldbaum G.M., Lockhart D., Kurth A., Rossini A., et al. Choosing HIV counseling and testing strategies for outreach settings: A randomized trial. Journal of Acquired Immune Deficiency Syndromes 38 (2005) 348-355
21. Stancliff S., Salomon N., Perlman D.C., and Russell P.C. Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange. Journal of Acquired Immune Deficiency Syndromes 18 (2000) 263-265
22. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 155 (2002) 645-653
23. Vlahov D., Des Jarlais D.C., Goosby E., Hollinger P.C., Lurie P.G., Shriver M.D., et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: Epidemiology and policy. American Journal of Epidemiology 154 Suppl 12 (2001) S70-S77